Device Trial Radar · NCT07414368
Case Series of StimLabs Dehydrated Human Umbilical Cord Particulate for Acute and Chronic Wounds
Last checked: Nov 20, 2026Latest source record: Apr 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
10
Planned (sponsor's estimate)
Start
Feb 11, 2026
Primary completion
Jun 2026
Study completion Jul 2026
Sponsor
- Lead sponsor
- StimLabsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 17, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this observational case series is to assess the use of Corplex P as a resorbable particulate device used to cover, protect, and provide a moist wound environment when added to the standard of care treatment of hard-to-heal wounds.
Conditions
- Chronic Ulcers
- Diabetic Foot Ulcers (DFU)
- DFU
- Ulcer
Interventions
Corplex P is used to cover, protect, and provide a moist wound environmentDevice
Corplex P is derived from human birth tissue and used in wound management to cover, protect, and provide a moist wound environment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of target ulcers achieving complete wound closure during the observational periodTime frame: 1-12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Family Foot & Ankle Specialists, LLC
Bridgeport, Connecticut
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.